Fragrance firms study possible GLP-1 scent link

Fragrance companies are investigating whether GLP-1 medicines are linked to changes in scent preferences, while perfumers expand ranges of food-inspired fragrances. The possible connection remains unproven, and companies and scientists say more research is needed to establish whether the medicines affect smell or fragrance choices. Givaudan, IFF, CPL Aromas and L’Oréal said they had examined potential links between GLP-1 use and fragrance preferences. Givaudan marketing executive Arnaud Guggenbuhl said the company had observed increased interest in fragrance among GLP-1 users and is broadening its gourmand offerings. These findings reflect company research and observations, not proof that the medicines cause changes in preference. NIQ research found that U.S. GLP-1 users spent 26% more on fragrances than the typical person. The comparison does not establish that medication use caused the difference. Anna Mayo, NIQ’s vice president of beauty and personal care thought leadership, said GLP-1 users spent more across many beauty categories. Scientists say a biological link is plausible but not yet understood. Paule Joseph, a scientist at the National Institutes of Health, said it...